期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (1)
Effects of sex hormones on stroke outcome are not fully understood. A deleterious consequence of cerebral ischemia is upregulation of vasoconstrictor ......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (2)
The use of a P2Y(12) inhibitor as a component of dual antiplatelet therapy in patients with an acute coronary syndrome (ACS) is well established. Howe......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (4)
This was a meta-analysis of randomized control trials (RCTs) to evaluate the effect of ivabradine on the risk of atrial fibrillation (AF) and its effe......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (4)
Background: Previous evidence supports that monoclonal antibodies that inhibit the proprotein convertase subtilisin/kexin type 9 (PCSK9) reduce low-de......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (5)
In cardiac myocytes, the slow component of the delayed rectifier K+ current (I-Ks) ensures repolarization of action potential during beta-adrenergic a......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (5)
This study was designed to investigate the role and mechanism of PIKfyve in the proliferation and migration of vascular smooth muscle cells (VSMCs) an......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (5)
Analysis of randomized controlled trials (RCTs) is the cornerstone of evidence-based medicine, therapeutic guidelines and ultimately daily practice. H......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (6)
Contrast-induced acute kidney injury (CI-AM) causes clinically acquired nephropathy in patients who undergo coronary interventions. Hypoxic injury to ......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 80 (1)
High glucose-induced endothelial activation plays critical roles in the development of diabetic vascular complications. R-spondin 3 could inhibit infl......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 80 (3)
Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance to the field of cardiovascular medicine due to the crit......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 79 (3)
Molecular circadian clocks exist in almost all cells of the organism and operate for approximately 24 hours, maintain the normal physiological and beh......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 80 (5)
Doxorubicin is a widely used anticancer drug in clinical practice, and its myocardial toxicity is the main concern in oncotherapy. Statins are commonl......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 80 (5)
Visfatin may play a role in vascular dysfunction in metabolic disorders. Apart from its insulin-mimetic actions, it has divergent actions in the cardi......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 80 (6)
Atrial fibrillation is the most common arrhythmia, ranging from 0.1% in patients < 55 years to > 9% in octogenarian patients. Polypharmacotherap......
期刊： JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022; 80 (6)
Dofetilide is an antiarrhythmic agent and primarily eliminated renally. Initial dosing is determined by creatinine clearance, calculated by total body......
